§285c–2 — Title 42 The Public Health and Welfare | U.S. Code

§285c–2 Division Directors for Diabetes, Endocrinology, and Metabolic Diseases, Digestive Diseases and Nutrition, and Kidney, Urologic, and Hematologic Diseases; functions

Title 42 › Chapter CHAPTER 6A— - PUBLIC HEALTH SERVICE › Subchapter SUBCHAPTER III— - NATIONAL RESEARCH INSTITUTES › Part Part C— - Specific Provisions Respecting National Research Institutes › Subpart subpart 3— - national institute of diabetes and digestive and kidney diseases › § 285c–2

Last updated Apr 6, 2026|Official source

Summary

The Institute must have three division directors: one for diabetes, endocrinology and metabolic diseases; one for digestive diseases and nutrition; and one for kidney, urologic and hematologic diseases. Working under the Institute Director, these division directors must create a coordinated plan (with spending recommendations) for NIH research and training on those conditions, check and improve management as needed, watch and review related spending, and find research opportunities and how to use them. The Institute Director must send those plans and reviews to the NIH Director with any comments. Using those division directors, the Institute Director must run research and training programs (except training paid by Ruth L. Kirschstein National Research Service Awards under section 288) for diagnosing, preventing, and treating those conditions. This includes support for medical school training, advanced clinical and epidemiology training, epidemiology studies, clinical trials, and interdisciplinary research, and it must set up evaluation, planning, and ways to share the knowledge gained.

Title 42, §285c–2

The Public Health and Welfare — Source: USLM XML via OLRC

(a)(1)In the Institute there shall be a Division Director for Diabetes, Endocrinology, and Metabolic Diseases, a Division Director for Digestive Diseases and Nutrition, and a Division Director for Kidney, Urologic, and Hematologic Diseases. Such Division Directors, under the supervision of the Director of the Institute, shall be responsible for—

(A)developing a coordinated plan (including recommendations for expenditures) for each of the national research institutes within the National Institutes of Health with respect to research and training concerning diabetes, endocrine and metabolic diseases, digestive diseases and nutrition, and kidney, urologic, and hematologic diseases;

(B)assessing the adequacy of management approaches for the activities within such institutes concerning such diseases and nutrition and developing improved approaches if needed;

(C)monitoring and reviewing expenditures by such institutes concerning such diseases and nutrition; and

(D)identifying research opportunities concerning such diseases and nutrition and recommending ways to utilize such opportunities.

(2)The Director of the Institute shall transmit to the Director of NIH the plans, recommendations, and reviews of the Division Directors under subparagraphs (A) through (D) of paragraph (1) together with such comments and recommendations as the Director of the Institute determines appropriate.

(b)The Director of the Institute, acting through the Division Director for Diabetes, Endocrinology, and Metabolic Diseases, the Division Director for Digestive Diseases and Nutrition, and the Division Director for Kidney, Urologic, and Hematologic Diseases, shall—

(1)carry out programs of support for research and training (other than training for which Ruth L. Kirschstein National Research Service Awards may be made under section 288 of this title) in the diagnosis, prevention, and treatment of diabetes mellitus and endocrine and metabolic diseases, digestive diseases and nutritional disorders, and kidney, urologic, and hematologic diseases, including support for training in medical schools, graduate clinical training, graduate training in epidemiology, epidemiology studies, clinical trials, and interdisciplinary research programs; and

(2)establish programs of evaluation, planning, and dissemination of knowledge related to such research and training.

Notes & Related Subsidiaries

Editorial Notes

Amendments

2002—Subsec. (b)(1). Pub. L. 107–206 substituted “Ruth L. Kirschstein National Research Service Awards” for “National Research Service Awards”. 1993—Subsec. (b). Pub. L. 103–43 substituted “the” for “the the” before “Division Director for Diabetes” in introductory provisions.